Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × inavolisib × Breast × Clear all

Phase

Status

Recruiting 8 Active not recruiting 3 Not yet recruiting 2 Terminated 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1 Breast Neoplasms 1

Interventions

Trastuzumab 73 Cyclophosphamide 57 Capecitabine 57 Docetaxel 53 Paclitaxel 51 Letrozole 42 Fulvestrant 39 Carboplatin 35 Lapatinib 33 pembrolizumab 31 Doxorubicin 31 Vinorelbine 28 Bevacizumab 28 Anastrozole 24 exemestane 23 Tamoxifen 20 Gemcitabine 20 Albumin-Bound Paclitaxel 20 Radiotherapy 17 pertuzumab 15 palbociclib 14 Everolimus 14 atezolizumab 13 Taxes 13 Magnetic Resonance Spectroscopy 13 Epirubicin 13 130-nm albumin-bound paclitaxel 13 eribulin 12 Goserelin 12 Ado-Trastuzumab Emtansine 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04849364 2025-05-31

PERSEVERE

Hoosier Cancer Research Network

Phase 2 Terminated

52 enrolled 16 charts

Breast Neoplasms, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡